Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Stagezero Life Sciences Ltd (SZLSF)

Stagezero Life Sciences Ltd (SZLSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
StageZero Life Sciences, Ltd. Announces Temporary Repricing of Warrants Expiring in 2023 and 2024 Newsfile - Tue Jun 20, 2023

Toronto, Ontario--(Newsfile Corp. - June 20, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) (OTCQB: SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0128 (-68.00%)
StageZero Life Sciences, Ltd Announces Results of Resolutions at Annual and Special Meeting Newsfile - Wed Jun 7, 2023

Toronto, Ontario--(Newsfile Corp. - June 7, 2023) - StageZero Life Sciences, Ltd (TSX: SZLS) (OTCQB: SZLSF) ("StageZero" or the "Company") is pleased to report that shareholders voted in favour of all...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0128 (-68.00%)
StageZero Life Sciences, Ltd. Special and Annual General Meeting Conference Call Newsfile - Mon Jun 5, 2023

Toronto, Ontario--(Newsfile Corp. - June 5, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) ("StageZero" or the "Company") today announced that it will host a conference call as part of its Special and...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0128 (-68.00%)
StageZero Life Sciences, Ltd Announces Q1 2023 Financial Results - 15.2% Growth in Revenue over Q4 2022 - and Operational Update Newsfile - Tue May 16, 2023

Toronto, Ontario--(Newsfile Corp. - May 16, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company"), a vertically-integrated healthcare company devoted to improving the early detection...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0128 (-68.00%)
StageZero to Issue Q1 2023 Financial Results After Market Closes May 15, 2023 Newsfile - Mon May 15, 2023

Toronto, Ontario--(Newsfile Corp. - May 15, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its first quarter 2023 operational results after...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0128 (-68.00%)
StageZero Life Sciences, Ltd Announces Q4 2022 and Year End Financial Results and Operational Update Newsfile - Fri Mar 31, 2023

Toronto, Ontario--(Newsfile Corp. - March 31, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company"), a vertically-integrated healthcare company devoted to improving the early detection...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0128 (-68.00%)
StageZero to Issue Q4 2022 Financial Results on Friday March 31 Newsfile - Thu Mar 30, 2023

Toronto, Ontario--(Newsfile Corp. - March 30, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its fourth quarter and year end 2022 operational...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0128 (-68.00%)
StageZero to Issue Q4 2022 Financial Results and Hold Conference Call on Thursday March 30 Newsfile - Wed Mar 29, 2023

Toronto, Ontario--(Newsfile Corp. - March 29, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its fourth quarter and year end 2022 operational...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0128 (-68.00%)
Results from METRICs Study Informs Expansion of StageZero's New Care Oncology Protocol Newsfile - Wed Feb 15, 2023

Launch of New Protocol will now make the connection between patients' metabolic health and cancer outcomes using advanced biomarker testing and interactive digital health platform to actively track patient...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0128 (-68.00%)
StageZero Life Sciences Announces Change of Date of Special Meeting of Shareholders; Will Combine with AGM in Q2 2023 Newsfile - Thu Feb 2, 2023

Toronto, Ontario--(Newsfile Corp. - February 2, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) (OTCQB: SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving...

SZLS.TO : 0.0400 (unch)
SZLSF : 0.0128 (-68.00%)

Barchart Exclusives

3 High-Yield Dividend Stocks Ready to Soar Barchart - Fri May 3, 6:00PM CDT
These three stocks are cheap, pay a high dividend, and are highly rated. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot